Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Altanserin
1. 79449-96-0
2. Altanserin Tartrate [usan]
3. 9p204che8j
4. 4(1h)-quinazolinone, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,3-dihydro-2-thioxo-, (r-(r*,r*))-2,3-dihydroxybutanedioate
5. Altanserin Tartrate (usan)
6. 3-(2-(4-(p-fluorobenzoyl)piperidino)ethyl)-2-thio-2,4(1h,3h)-quinazolinedione L-(+)-tartrate (1:1)
7. R-53,200
8. Unii-9p204che8j
9. R-53200
10. Einecs 279-159-5
11. Schembl124036
12. Dtxsid20229675
13. D02836
14. Q27272848
15. (2r,3r)-2,3-dihydroxybutanedioic Acid;3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2-sulfanylidene-1h-quinazolin-4-one
16. 3-(2-(4-(4-fluorobenzoyl)piperidino)ethyl)-2,3-dihydro-2-thioxoquinazolin-4(1h)-one (r-(r*,r*))-tartrate
| Molecular Weight | 561.6 g/mol |
|---|---|
| Molecular Formula | C26H28FN3O8S |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 8 |
| Exact Mass | 561.15811420 g/mol |
| Monoisotopic Mass | 561.15811420 g/mol |
| Topological Polar Surface Area | 200 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 763 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
ABOUT THIS PAGE
A Altanserin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Altanserin, including repackagers and relabelers. The FDA regulates Altanserin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Altanserin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Altanserin supplier is an individual or a company that provides Altanserin active pharmaceutical ingredient (API) or Altanserin finished formulations upon request. The Altanserin suppliers may include Altanserin API manufacturers, exporters, distributors and traders.
click here to find a list of Altanserin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Altanserin DMF (Drug Master File) is a document detailing the whole manufacturing process of Altanserin active pharmaceutical ingredient (API) in detail. Different forms of Altanserin DMFs exist exist since differing nations have different regulations, such as Altanserin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Altanserin DMF submitted to regulatory agencies in the US is known as a USDMF. Altanserin USDMF includes data on Altanserin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Altanserin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Altanserin suppliers with USDMF on PharmaCompass.
Altanserin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Altanserin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Altanserin GMP manufacturer or Altanserin GMP API supplier for your needs.
A Altanserin CoA (Certificate of Analysis) is a formal document that attests to Altanserin's compliance with Altanserin specifications and serves as a tool for batch-level quality control.
Altanserin CoA mostly includes findings from lab analyses of a specific batch. For each Altanserin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Altanserin may be tested according to a variety of international standards, such as European Pharmacopoeia (Altanserin EP), Altanserin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Altanserin USP).
LOOKING FOR A SUPPLIER?
